Extended RAS Testing in mCRC for EGFRi: @ASCO Provisional Opinion [10/6/15] - Allegra Rumble @rschilsky #JCO https://t.co/kItIw0jhKN #crcsm
RT @ASCO: The latest RAS Provisional Clinical Opinion Update http://t.co/9r9A3ruv4o #JOP
Extended RAS Testing in mCRC for EGFRi: @ASCO Provisional Opinion [10/6/15] - Allegra Rumble @rschilsky #JCO http://t.co/kItIw0jhKN #crcsm
RT @ASCO: The latest RAS Provisional Clinical Opinion Update http://t.co/9r9A3ruv4o #JOP
The latest RAS Provisional Clinical Opinion Update http://t.co/9r9A3ruv4o #JOP
Extended RAS Gene Mutation Testing in Metastatic CRC to Predict Response to Anti–EGFR Monoclonal Antibody Therapy http://t.co/QSViGukGcJ
Ext RAS Testing in MCC to Predict Response to Anti–EGFR MoAb Tx PCO Summary http://t.co/6cVcTpjUoz #JCO @ASCO @iConquerCancer @CancerDotNet